Search results for "pond"

showing 10 items of 742 documents

The success (or not) of HUGO nomenclature.

2006

A literature search shows that biologists do not follow the official nomenclature guidelines for a substantial fraction of gene names.

GenesTerminology as TopicCorrespondenceHumansGuidelines as TopicGenome biology
researchProduct

Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis

2017

BackgroundDysbiosis has been recently demonstrated in patients with ankylosing spondylitis (AS) but its implications in the modulation of intestinal immune responses have never been studied. The aim of this study was to investigate the role of ileal bacteria in modulating local and systemic immune responses in AS.MethodsIleal biopsies were obtained from 50 HLA-B27+ patients with AS and 20 normal subjects. Silver stain was used to visualise bacteria. Ileal expression of tight and adherens junction proteins was investigated by TaqMan real-time (RT)-PCR and immunohistochemistry. Serum levels of lipopolysaccharide (LPS), LPS-binding protein (LPS-BP), intestinal fatty acid-BP (iFABP) and zonulin…

Genetics and Molecular Biology (all)Fatty Acid-Binding ProteinAnkylosing SpondylitisMonocyteBiochemistryMonocytesTransgenic0302 clinical medicineIntestinal MucosaMembrane GlycoproteinsZonulinCadherinsAdherens JunctionUp-RegulationAntigenAcute DiseaseMembrane GlycoproteinRats TransgenicInfectionHumanAnkylosingImmunologyGeneral Biochemistry Genetics and Molecular BiologyArticlePermeabilityTight Junctions03 medical and health sciencesRheumatologyAntigens CDIleumAnti-Bacterial AgentHuman Umbilical Vein Endothelial CellsHumansRNA MessengerEndotheliumProtein PrecursorsAnkylosing SpondylitiBiochemistry Genetics and Molecular Biology (all)BacteriaAnimalmedicine.diseaseDysbiosiSettore MED/16 - Reumatologia030104 developmental biologychemistryCase-Control StudiesImmunologyRatCarrier ProteinsAcute-Phase ProteinsSpondylitis0301 basic medicineLipopolysaccharidesLipopolysaccharideMessengerAcute-Phase ProteinGene Expressionchemistry.chemical_compoundIntestinal mucosaImmunology and AllergyMembrane ProteinHLA-B27 AntigenCaco-2 CellTight junctionTight JunctionAdherens JunctionsIleitisIleitiAnti-Bacterial AgentsCDmedicine.anatomical_structureAnkylosing Spondylitis; Infections; Inflammation; Acute Disease; Acute-Phase Proteins; Adherens Junctions; Animals; Anti-Bacterial Agents; Antigens CD; Bacteria; Caco-2 Cells; Cadherins; Carrier Proteins; Case-Control Studies; Cholera Toxin; Chronic Disease; Dysbiosis; Endothelium; Fatty Acid-Binding Proteins; Gene Expression; HLA-B27 Antigen; Human Umbilical Vein Endothelial Cells; Humans; Ileitis; Ileum; Interleukin-8; Intestinal Mucosa; Junctional Adhesion Molecule A; Lipopolysaccharides; Membrane Glycoproteins; Membrane Proteins; Monocytes; Permeability; RNA Messenger; Rats; Rats Transgenic; Spondylitis Ankylosing; Tight Junctions; Up-Regulationmedicine.symptomCase-Control StudieCholera ToxinHuman Umbilical Vein Endothelial CellLipopolysaccharideInflammationInfectionsFatty Acid-Binding ProteinsAdherens junctionmedicineAnkylosing Spondylitis; Infections; Inflammation; Acute Disease; Acute-Phase Proteins; Adherens Junctions; Animals; Anti-Bacterial Agents; Antigens CD; Bacteria; Caco-2 Cells; Cadherins; Carrier Proteins; Case-Control Studies; Cholera Toxin; Chronic Disease; Dysbiosis; Endothelium; Fatty Acid-Binding Proteins; Gene Expression; HLA-B27 Antigen; Human Umbilical Vein Endothelial Cells; Humans; Ileitis; Ileum; Interleukin-8; Intestinal Mucosa; Junctional Adhesion Molecule A; Lipopolysaccharides; Membrane Glycoproteins; Membrane Proteins; Monocytes; Permeability; RNA Messenger; Rats; Rats Transgenic; Spondylitis Ankylosing; Tight Junctions; Up-Regulation; Immunology and Allergy; Rheumatology; Immunology; Biochemistry Genetics and Molecular Biology (all)AnimalsSpondylitis AnkylosingAntigensSpondyliti030203 arthritis & rheumatologyInflammationHaptoglobinsbusiness.industryMonocyteInterleukin-8Membrane ProteinsRatsJunctional Adhesion Molecule AChronic DiseaseCadherinDysbiosisRNACaco-2 CellsCarrier ProteinbusinessDysbiosis
researchProduct

Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease.

2017

Vedolizumab (VDZ) is a new biological agent which was recently approved for the treatment of inflammatory bowel disease (IBD)1 following the good clinical responses reported by clinical trials for both Crohn's disease2 and ulcerative colitis.3 However, the effects of VDZ on extraintestinal manifestations were not reported in these trials, and the ‘real life’ experience is still limited. On these premises, we read with interest the recent work by Varkas et al 4 reporting a series of five patients with IBD who were treated with VDZ and promptly developed new onset or exacerbation of spondyloarthritis (SpA), irrespective of the response to treatment on intestinal symptoms. Although the hypothe…

Genetics and Molecular Biology (all)medicine.medical_specialtyExacerbationT CellImmunologyPremisesAntibodies Monoclonal HumanizedBiochemistryInflammatory bowel diseaseGastroenterologyGeneral Biochemistry Genetics and Molecular BiologyNew onsetVedolizumab03 medical and health sciences0302 clinical medicineRheumatologyInternal medicineSpondylarthritismedicineImmunology and AllergyHumansIn patientSacroiliitis030203 arthritis & rheumatologyBiochemistry Genetics and Molecular Biology (all)business.industrymedicine.diseaseInflammatory Bowel Diseasesdigestive system diseasesRheumatologyTreatmentClinical trial030211 gastroenterology & hepatologySpondyloarthritis; T Cells; Treatment; Rheumatology; Immunology and Allergy; Immunology; Biochemistry Genetics and Molecular Biology (all)Spondyloarthritibusinessmedicine.drugAnnals of the rheumatic diseases
researchProduct

Comment on “Controversies about Interspinous Process Devices in the Treatment of Degenerative Lumbar Spine Diseases: Past, Present, and Future”

2017

Genetics and Molecular Biology (all)medicine.medical_specialtyImmunology and Microbiology (all)Spinal stenosisMEDLINElcsh:MedicineLumbar vertebraeBiochemistryGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicinemedicine030212 general & internal medicineProcess (anatomy)General Immunology and Microbiologybusiness.industrylcsh:RGeneral Medicinemedicine.diseaseSpondylarthritisSurgerymedicine.anatomical_structureInterspinous Process Devices Degenerative Lumbar Spine DiseasesLumbar spinebusinessBiochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)030217 neurology & neurosurgeryBioMed Research International
researchProduct

Predominance of the fimH30 Subclone Among Multidrug-Resistant Escherichia coli Strains Belonging to Sequence Type 131 in Italy

2013

GeneticsSettore MED/07 - Microbiologia E Microbiologia ClinicaST131 E. coli fimH30 sub-clone in ItalyBiologymedicine.disease_causeAnti-Bacterial AgentsMicrobiologyMultiple drug resistanceInfectious DiseasesType (biology)Drug Resistance Multiple BacterialCorrespondenceEscherichia colimedicineHumansImmunology and AllergyEscherichia coliEscherichia coli InfectionsFluoroquinolonesSequence (medicine)Journal of Infectious Diseases
researchProduct

Dendrochemical assessment of mercury releases from a pond and dredged-sediment landfill impacted by a chlor-alkali plant.

2016

International audience; Although current Hg emissions from industrial activities may be accurately monitored, evidence of past releases to the atmosphere must rely on one or more environmental proxies. We used Hg concentrations in tree cores collected from poplars and willows to investigate the historical changes of Hg emissions from a dredged sediment landfill and compared them to a nearby control location. Our results demonstrated the potential value of using dendrochemistry to record historical Hg emissions from past industrial activities.

Geologic Sediments010504 meteorology & atmospheric scienceschemistry.chemical_elementIndustrial Waste[INFO.INFO-SE]Computer Science [cs]/Software Engineering [cs.SE]010501 environmental sciencesGeologic SedimentsAlkalies01 natural sciencesBiochemistryIndustrial waste[ SDV.EE ] Life Sciences [q-bio]/Ecology environmentTrees[INFO.INFO-IU]Computer Science [cs]/Ubiquitous Computing[INFO.INFO-CR]Computer Science [cs]/Cryptography and Security [cs.CR]Waste Disposal Facilityddc:550Salicaceous speciesPondsComputingMilieux_MISCELLANEOUS0105 earth and related environmental sciencesGeneral Environmental Science[SDV.EE]Life Sciences [q-bio]/Ecology environmentChlor-alkali plantEcologyTree ringsSalixMercury[INFO.INFO-MO]Computer Science [cs]/Modeling and SimulationMercury (element)Waste Disposal FacilitiesPopuluschemistry13. Climate action[INFO.INFO-MA]Computer Science [cs]/Multiagent Systems [cs.MA]Environmental chemistryEnvironmental scienceDendrochemistry[INFO.INFO-ET]Computer Science [cs]/Emerging Technologies [cs.ET]Environmental Pollutants[INFO.INFO-DC]Computer Science [cs]/Distributed Parallel and Cluster Computing [cs.DC]Environmental research
researchProduct

Interventions to prevent, delay or reverse frailty in older people: a journey towards clinical guidelines

2019

AbstractBackgroundAge-related frailty is a multidimensional dynamic condition associated with adverse patient outcomes and high costs for health systems. Several interventions have been proposed to tackle frailty. This correspondence article describes the journey through the development of evidence- and consensus-based guidelines on interventions aimed at preventing, delaying or reversing frailty in the context of the FOCUS (Frailty Management Optimisation through EIP-AHA Commitments and Utilisation of Stakeholders Input) project (664367-FOCUS-HP-PJ-2014). The rationale, framework, processes and content of the guidelines are described.Main textThe guidelines were framed into four questions …

GerontologyGRADE systemProcess (engineering)media_common.quotation_subjectPsychological interventionlcsh:MedicineContext (language use)GuidelinesAffect (psychology)03 medical and health sciences0302 clinical medicineCorrespondenceHumansMedicineQuality (business)030212 general & internal medicineExerciseGeriatric AssessmentQualitative ResearchInterventionsAgedmedia_commonAged 80 and overFrailtybusiness.industrylcsh:RGeneral MedicineCognitive trainingImplementationOlder peoplebusinessOlder people030217 neurology & neurosurgeryDecision-makingQualitative researchBMC Medicine
researchProduct

Implications of obesity in exceptional longevity.

2016

Except for the world’s poorest regions, it is estimated that global obesity [body mass index (BMI) >30 kg/m 2 ] prevalence will reach 18% (men) and >21% (women) by 2025 (1). Recent nationally representative surveys in the US for the 2013–2014 period indicate age-adjusted obesity prevalence of 35.0% and 40.4% among adult men and women, respectively (2) and of 17.0% for children and adolescents aged 2–19 years (3).

Gerontologybusiness.industry030503 health policy & servicesmedia_common.quotation_subjectAncianoLongevityObesidadGeneral Medicinemedicine.diseaseObesity03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisLongevidadCorrespondencemedicine0305 other medical sciencebusinessBody mass indexDemographymedia_commonAnnals of translational medicine
researchProduct

COVID-19 psychological impact in 3109 healthcare workers in Spain: The PSIMCOV group

2020

AbstractBackgroundThe current coronavirus disease (COVID-19) has a great impact worldwide. Healthcare workers play an essential role and are one of the most exposed groups. Information about the psychosocial impact on healthcare workers is limited.Methods3109 healthcare workers completed a national, internet-based, cross-sectional 45-item survey between 9 and 19 April 2020. The objective is to assess the psychological impact of the COVID-19 pandemic in Spanish healthcare workers. A Psychological Stress and Adaptation at work Score (PSAS) was defined combining four modified versions of validated psychological assessment tests (A) Healthcare Stressful Test, (B) Coping Strategies Inventory, (C…

Gerontologymedicine.medical_specialtyHealth PersonnelDisease03 medical and health sciences0302 clinical medicineHealth careCorrespondenceMedicineHumansPsychological testing030212 general & internal medicinePandemicsApplied PsychologyGeriatricsbusiness.industryhealthcare workersSARS-CoV-2Incidence (epidemiology)pandemicCOVID-19Middle AgedMental healthDistressPsychiatry and Mental healthCross-Sectional StudiesSpainpsychologicalbusinessPsychosocial030217 neurology & neurosurgerymental healthPsychological Medicine
researchProduct

On the non-malacostracan crustaceans (Crustacea: Branchiopoda, Copepoda, Ostracoda) from the inland waters of Fthiotida (Greece)

2019

In the frame of the activities of the LIFE11 NAT/GR/1014 ForOpenForests, some water bodies occurring in the "Ethnikos Drymos Oitis" (GR2440004) and "Oros Kallidromo" (GR2440006) (Sterea Ellada) were investigated with the aim of providing a first census of the composition and diversity of their crustacean fauna. Overall, the sampling of 15 water bodies (7 of them listed as "Mediterranean temporary ponds" sensu EU "Habitats Directive") led to the finding of 13 branchiopod, 11 copepod, and 7 ostracod taxa, including 4 species new for mainland Greece, i.e. the copepods Arctodiaptomus alpinus (Imhoff, 1885) and Diaptomus cf. serbicus, and the branchiopods Leptestheria dahalacensis (Rüppel, 1837)…

Global and Planetary ChangeArctodiaptomus alpinus Cross-taxon congruence Diaptomuscf.serbicus Leptestheria dahalacensisTemporary pondsWlassicsia pannonica.EcologybiologyEcologyFaunaWlassicsia pannonicaCross-taxon congruenceSettore BIO/05 - ZoologiaBranchiopodaLeptestheria dahalacensisGénéralitésTemporary pondsArctodiaptomus alpinusbiology.organism_classificationCrustaceanDiaptomusGeographyOstracodDiaptomus cf. serbicusHabitats DirectiveSpecies richnessEcology Evolution Behavior and SystematicsCopepod
researchProduct